Immunovant
$25.15
57
+$0.31+1.25% Today
Statistics
Day High
25.87
Day Low
25
52W High
29.25
52W Low
12.72
Volume
212,878
Avg. Volume
1,396,555
Mkt Cap
5.12B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
3JunExpected
Expected EPS
-0.599452
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-827.68MNet Income
Analyst Ratings
$35.80Average Price Target
The highest estimate is 50.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy 60%
Hold 40%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow IMVT. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Argen X
ARGX
Mkt Cap50.39B
United Community Banks
UCB
Mkt Cap3.57B
Abbvie
ABBV
Mkt Cap385.18B
AMGEN
AMGN
Mkt Cap160.66B
GSK
GSK
Mkt Cap94.51B
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Novartis
NVS
Mkt Cap237.61B
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
About
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company was incorporated in 2018 is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.
Show more...
CEO
Dr. Frank M. Torti M.B.A., M.D.
Employees
362
Country
US
ISIN
US45258J1025
Listings
0 Comments
Share your thoughts
FAQ
What is Immunovant stock price today?▼
The current price of IMVT is $25.15 USD — it has increased by +1.25% in the past 24 hours. Watch Immunovant stock price performance more closely on the chart.
What is Immunovant stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Immunovant stocks are traded under the ticker IMVT.
Is Immunovant stock price growing?▼
IMVT stock has risen by +1.98% compared to the previous week, the month change is a -8.94% fall, over the last year Immunovant has showed a +66.12% increase.
What is Immunovant market cap?▼
Today Immunovant has the market capitalization of 5.12B
When is the next Immunovant earnings date?▼
Immunovant is going to release the next earnings report on June 03, 2026.
What were Immunovant earnings last quarter?▼
IMVT earnings for the last quarter are -0.61 USD per share, whereas the estimation was -0.71 USD resulting in a +14.5% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Immunovant revenue for the last year?▼
Immunovant revenue for the last year amounts to 0 USD.
What is Immunovant net income for the last year?▼
IMVT net income for the last year is -827.68M USD.
How many employees does Immunovant have?▼
As of April 01, 2026, the company has 362 employees.
In which sector is Immunovant located?▼
Immunovant operates in the Health Care sector.
When did Immunovant complete a stock split?▼
Immunovant has not had any recent stock splits.
Where is Immunovant headquartered?▼
Immunovant is headquartered in New York, US.